Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.

Ferreri, Andrés J M

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. [electronic resource] - Blood advances 03 2020 - 1013-1019 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

2473-9537

10.1182/bloodadvances.2020001459 doi


Adult
Conjunctiva
Humans
Lymphoma, B-Cell, Marginal Zone--drug therapy
Neoplasm Recurrence, Local
Prospective Studies
Rituximab